A PSA report is not a cancer diagnosis. PSA is a prostate-derived blood marker, not a cancer-specific test. It can rise with benign prostate enlargement, prostatitis or urinary infection, acute urinary retention, recent ejaculation and prostate manipulation or procedures, as well as prostate cancer. A smooth urinary catheter by itself usually has little effect; retention, infection and traumatic instrumentation are more relevant. An unexpected result should be confirmed and interpreted in context before deciding on MRI or biopsy.

What is a PSA test?

PSA stands for prostate-specific antigen. It is a protein made by the prostate gland. A small amount normally enters the blood.

A PSA test measures this protein in your blood, usually reported as ng/mL. It may be used to:

PSA is best understood as a prostate signal, not a final diagnosis. It tells the doctor that the prostate needs interpretation in context.

What PSA does not mean

This is the most important part. A PSA report should be read like a clinical clue, not like a verdict.

Who should consider a PSA test?

You should discuss PSA testing with a urologist if:

• You are around 45-50 years and want to discuss baseline, risk-based PSA testing.
• You are around 40-45 years and have increased risk, such as a strong family history or a known cancer-predisposition mutation.
• Your father or brother had prostate cancer.
• More than one close male relative had prostate cancer.
• There is a family history of BRCA-related cancers, such as prostate, breast, ovarian or pancreatic cancer.
• You have urinary symptoms such as weak stream, frequent urination or night urination.
• You have blood in urine or semen.
• You are being followed after prostate cancer treatment.

Most guidelines recommend shared decision-making for screening, meaning the test should be done after discussing benefits, limitations and your personal risk.

How to prepare before a PSA test

Small things can temporarily raise PSA and create unnecessary anxiety.

• Avoid ejaculation for 48 hours.
• If practical, avoid prolonged cycling or heavy perineal pressure before testing. Evidence for a clinically important cycling-related PSA rise is less consistent than for infection, retention or ejaculation.
• Do not test during active urine infection, fever or prostatitis unless your doctor advises it.
• Tell your doctor if you recently had acute urinary retention, a difficult or traumatic catheterisation, cystoscopy, prostate biopsy or prostate surgery. The timing and type of instrumentation matter.
• Tell your doctor if you take finasteride or dutasteride.
• Do not stop any prostate medicine on your own.
• Fasting is usually not required.

If PSA was measured during an active urinary infection, prostatitis or acute urinary retention, it may not reflect your usual baseline. A smooth catheter alone is not a reliable explanation for a high PSA.

What is a normal PSA level?

There is no single perfect normal PSA for every man.

Many labs mark PSA below 4 ng/mL as normal, but doctors do not depend only on that cutoff. A PSA of 3.8 may be more important in a 48-year-old man with family history than a PSA of 5.2 in a 75-year-old man with a very large benign prostate.

Why can PSA be high?

Common causes include:

• Benign prostate enlargement, also called BPH.
• Prostatitis, meaning inflammation of the prostate.
• Urinary tract infection.
• Recent ejaculation.
• Prolonged cycling or heavy perineal pressure may cause a small temporary rise in some men.
• Urinary retention.
• Traumatic urinary instrumentation, especially when associated with retention or infection.
• Cystoscopy or prostate procedure.
• Recent prostate biopsy.
• Prostate cancer.

This is why a raised PSA should be evaluated calmly. A high PSA should not be ignored, but it should also not be converted into a cancer diagnosis without proper assessment.

What happens if PSA is high?

A good urology evaluation follows a step-by-step pathway:

1. Check infection, medicines and recent PSA triggers.
2. Repeat PSA if appropriate.
3. Assess age, prostate size, PSA density and PSA trend.
4. Consider MRI prostate if risk remains significant.
5. Advise biopsy only if clinically indicated.

For a newly raised PSA, AUA guidance supports repeating PSA before moving to biomarkers, imaging or biopsy in appropriate cases. EAU guidance also notes that repeat testing can be useful when PSA is moderately elevated.

When does MRI prostate help?

A multiparametric MRI prostate gives detailed images of the prostate. It helps the doctor:

• Measure prostate size.
• Calculate PSA density.
• Look for suspicious areas.
• Decide whether biopsy is needed.
• Guide targeted biopsy if biopsy is required.

If MRI is reassuring and PSA density is low, some men can avoid immediate biopsy and remain under follow-up. If MRI shows a suspicious lesion, biopsy may be advised.

When is prostate biopsy needed?

A biopsy is the test that confirms prostate cancer. PSA alone cannot confirm it.

Biopsy may be advised if:

• PSA remains high after repeat testing.
• PSA is rising over time.
• MRI shows a suspicious lesion.
• Prostate examination is abnormal.
• PSA density is high.
• There is strong family history or high-risk background.
• PSA remains unexplained after treating infection or inflammation.

A biopsy is not a punishment and not a sign that cancer is certain. It is a confirmation test used when the risk is high enough to justify tissue diagnosis.

Common PSA scenarios in real OPD

Myths and facts about PSA

When should you see a urologist?

See a urologist if:

• PSA is above the lab range.
• PSA is rising compared with previous reports.
• PSA is high despite no infection.
• You have urinary symptoms with raised PSA.
• You have blood in urine or semen.
• You have recurrent urinary infection.
• You have a family history of prostate cancer.
• PSA is high while taking finasteride or dutasteride.
• You are confused about whether you need MRI or biopsy.

What to bring for consultation

• Current PSA report with date.
• Previous PSA reports, even if normal.
• Urine routine and urine culture.
• Ultrasound KUB/prostate/PVR report.
• Uroflowmetry report, if done.
• MRI prostate report and images, if done.
• Prostate biopsy/HPE report, if done.
• Current medicines, especially finasteride, dutasteride, blood thinners or antibiotics.
• Catheterisation, TURP, HoLEP or prostate surgery discharge summary.
• Family history details of prostate cancer.

FAQs

Related reading

• Frequent Urination in Men
• Uroflowmetry Test Explained
• TURP Surgery: Procedure, Recovery and Risks
• HoLEP Surgery: Procedure, Recovery and Benefits
• When Should Indian Men Do PSA Test?
• Prostate Enlargement / BPH
• Prostate Cancer
• Urologist in Latur

References

• National Cancer Institute. Prostate-Specific Antigen Test.
• European Association of Urology. EAU Guidelines on Prostate Cancer: Diagnostic Evaluation, 2026.
• EAU Patient Information: Understanding the PSA Test.
• British Association of Urological Surgeons. Raised PSA.
• NICE Guideline NG131: Prostate Cancer Diagnosis and Management.
• AUA/SUO Early Detection of Prostate Cancer Guideline, amended 2026.